Ignite Creation Date:
2025-12-25 @ 1:32 AM
Ignite Modification Date:
2026-02-20 @ 6:25 PM
Study NCT ID:
NCT03689894
Status:
TERMINATED
Last Update Posted:
2023-11-28
First Post:
2018-09-27
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Ibrutinib Plus Rituximab for cGVHD Following Allo-SCT
Sponsor:
Organization: